ArticleFrontiers in immunology2023

Incorporation of a TGF-β2-inhibiting oligodeoxynucleotide molecular adjuvant into a tumor cell lysate vaccine to enhance antiglioma immunity in mice.

Liqun Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.